Is enVVeno Medical Corp (NVNO) Halal?

NASDAQ Healthcare United States $7M
✗ NOT HALAL
Confidence: 83/100
enVVeno Medical Corp (NVNO) is Not Halal under AAOIFI Standard 21. While the debt ratio of 14.2% is acceptable, the cash and interest-bearing securities ratio of 574.3% exceeds the 30% threshold. enVVeno Medical Corp operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 14.2%
/ 30%
574.3%
/ 30%
0.0%
/ 30%
N/A ✗ NOT HALAL
DJIM 14.2%
/ 33%
574.3%
/ 33%
0.0%
/ 33%
N/A ✗ NOT HALAL
MSCI 2.4%
/ 33%
96.0%
/ 33%
0.0%
/ 33%
N/A ✗ NOT HALAL
S&P 14.2%
/ 33%
574.3%
/ 33%
0.0%
/ 33%
N/A ✗ NOT HALAL
FTSE 2.4%
/ 33%
96.0%
/ 33%
0.0%
/ 50%
N/A ✗ NOT HALAL

Financial Highlights

EPS
$-33.06
P/B Ratio
0.2
EV/EBITDA
1.0
EV: -$24M
Revenue
$0
Beta
1.1
Average volatility
Current Ratio
13.1

Profitability

Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
Return on Equity (ROE) -57.2%
Return on Assets (ROA) -35.1%

Cash Flow & Balance Sheet

Operating Cash Flow-$17M
Free Cash Flow-$17M
Total Debt$1M
Debt-to-Equity2.7
Current Ratio13.1
Total Assets$45M

Price & Trading

Last Close$10.51
50-Day MA$10.71
200-Day MA$51.73
Avg Volume22K
Beta1.1
52-Week Range
$8.67
$196.70

About enVVeno Medical Corp (NVNO)

CEO
Mr. Robert A. Berman
Employees
37
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$7M
Currency
USD

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is enVVeno Medical Corp (NVNO) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), enVVeno Medical Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is enVVeno Medical Corp's debt ratio?

enVVeno Medical Corp's debt ratio is 14.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.4%.

What are enVVeno Medical Corp's key financial metrics?

enVVeno Medical Corp has a market capitalization of $7M. Return on equity stands at -57.2%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.